Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Riederer

Showing results (231-240 of 244) with videos related to

Pageof 25
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 16, 2016
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognitionBorwin Bandelow, David Baldwin, Marianna Abelli, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 27, 2016
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanismsAndrea Schmitt, Daniel Martins-de-Souza, Schahram Akbarian, et al.
Acta Neuropathologica|March 28, 2008
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortiumJeanne E Bell, Irina Alafuzoff, Safa Al-Sarraj, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 3, 2017
The diabetic brain and cognitionPeter Riederer, Amos D Korczyn, Sameh S Ali, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Der Nervenarzt|July 17, 2019
[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Proteomics|August 24, 2006
HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategyMichael Hamacher, Rolf Apweiler, Georg Arnold, et al.
Science Translational Medicine|October 8, 2010
PGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseBin Zheng, Zhixiang Liao, Joseph J Locascio, et al.
Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.
Pageof 25

Showing results (231-240 of 244) with videos related to

Sort By:
Pageof 25
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 16, 2016
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognitionBorwin Bandelow, David Baldwin, Marianna Abelli, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 27, 2016
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanismsAndrea Schmitt, Daniel Martins-de-Souza, Schahram Akbarian, et al.
Acta Neuropathologica|March 28, 2008
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortiumJeanne E Bell, Irina Alafuzoff, Safa Al-Sarraj, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 3, 2017
The diabetic brain and cognitionPeter Riederer, Amos D Korczyn, Sameh S Ali, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 2, 2018
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, et al.
Der Nervenarzt|November 18, 2018
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Der Nervenarzt|July 17, 2019
[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]Stefan Unterecker, Gudrun Hefner, Pierre Baumann, et al.
Proteomics|August 24, 2006
HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategyMichael Hamacher, Rolf Apweiler, Georg Arnold, et al.
Science Translational Medicine|October 8, 2010
PGC-1α, a potential therapeutic target for early intervention in Parkinson's diseaseBin Zheng, Zhixiang Liao, Joseph J Locascio, et al.
Pharmacopsychiatry|July 2, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspectsXenia M Hart, Gerhard Gründer, Christoph Hiemke, et al.
Pageof 25